EBAG9 and neoplasm: This conclusion is substantiated by only partial correlation between endogenous EBAG9 protein levels and the corresponding expression profiles for the 22-1-1 antigen in human tumor cell lines, as determined by immunoblotting or flow cytometry, respectively.